The potential of herbal mineral formulation Rasa Parpam (R.P.) as an anti-cervical carcinoma, antitumor and anti-microbiological evaluation (A Siddha medicine for cervical cancer) in in-vitro studies

Abstract

One of the most fatal diseases of the Twentieth century, cancer is becoming solitary of the majority prevalent diseases of the Twenty-first century. Cervical cancer is a form of carcinoma that affects cervix cells. Cervical cancer is a highly prevalent carcinoma among women under the mandatory age of 35. These objectives were fulfilled to treat cervical cancer with a Siddha medicine formulation, assist those affected by the disease, and investigate to ascertain Rasa Parpam's pharmacological activity (in vitro anticancer activity), as well as to assess the therapeutic effects of Rasa Parpam and to measure antitumor activity against HeLa and SiHa cell lines as well as anticancer activity (MTT assay), and to validate the therapeutic effects of Rasa Parpam. Cervical cancer must be treated appropriately in the medical environment of today. In the MTT experiment, the lowest cell viability was found at an attention of 300 µg per millilitre, showing 36.24 ±2.854%. This was tracked by attention of 200 µg per millilitre, 100 µg per millilitre also 10 µg per millilitre, showing 52.86±3.014, 63.48±3.264, and 91.59 ±3.386% respectively. It was discovered that the equivalent IC50 assessment was 139.35 ± 5.863 µg per millilitre. The formulation R.P. has promised anticancer activity, according to the current study's findings. R.R. is proving to be a potent cervical cancer preventative. It has a variety of pharmacological effects, including antimicrobial and anticancer effects. This cancer treatment is affordable and has no unfavorable side effects. Scientific journals have reported on the anticancer effects of R.P. The anticancer action of R.P. is discussed in this work in the context of several in-vitro with in-vivo studies.